0 CHECKOUT

PRODUCT FILTERS

REGION

720
392
389
364
364

COUNTRY

354
48
22
20
19

CATEGORIES

  • 262
  • 252
  • 197
  • 192
  • 183
  • 164
  • 147
  • 145
  • 143
  • 126
  • 117
  • 113
  • 60
  • 58
  • 40

PRICE

158
670
1,167
2,632

PUBLISHED

667
777
1,420
2,632

PRODUCT TYPE

2,512
114
3
2
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Active Pharmaceutical Ingredient Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, Nephrology, Ophthalmology) - Global Forecast to 2020

Factors such as the increasing incidence of life style and age related diseases, Increasing prevalence of cancer across the world, Technological advancements in the APIs Manufacturing, Emerging markets...

Published:  October 2015
Price:  From

Immunotherapy Drugs Market by Type of Drug, Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020

In this report, the immunotherapy market is segmented into types of drugs and region. By types of drug, the market is further subsegmented into antibodies, interferons, interleukins, vaccines and checkpoint...

Published:  December 2015
Price:  From

World Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics - Market Opportunity and Forecast, 2014 - 2020

Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining...

Published:  July 2015
Price:  From

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

Published:  January 2016
Price:  From

Malignant Melanoma Pricing and Reimbursement

With several new high cost melanoma drugs available, payer decisions on whether patients can access those drugs and under what conditions are becoming more important than ever. This report covers both...

Published:  September 2015
Price:  From

Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

The report on breast cancer therapeutics: pipeline analysis market studies the future market of breast cancer drugs on the basis of the molecules which are currently under pipeline. Breast cancer usually...

Published:  August 2015
Price:  From

Glioblastoma Multiforme Treatment (GBM) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

Glioblastoma multiforme (GBM) is the most frequent and lethal primary brain tumor in adults. The current treatment modalities available in the market are surgical resection followed by chemotherapy...

Published:  June 2015
Price:  From

Oncology Pathways in the US - Friend or Foe for Pharma?

The costs of treating cancer in the US are spiralling upward, and payers have taken notice. This report takes a detailed look at the growing focus on value and quality that is driving greater use of...

Published:  July 2015
Price:  From

Kidney Cancer Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

'Kidney Cancer Drugs Market (Major Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Inlyta (Axitinib), Nexavar (Sorafenib), Proleukin (Aldesleukin), Sutent (Sunitinib), Torisel (Temsirolimus), Votrient...

Published:  January 2015
Price:  From

CINV Existing and Pipeline Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

'CINV Existing and Pipeline Drugs Market (Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL and Rolapitant) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020' Chemotherapy...

Published:  December 2014
Price:  From

Colorectal Cancer Therapeutics Market in APAC 2015-2019

About colorectal cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature...

Published:  December 2015
Price:  From

Cancer Bundle

The Cancer Bundle offers a 15% discount off the total transaction price for the following reports being purchased simultaneously: - Biomarker Technology Platforms for Cancer Diagnoses and Therapies -...

Published:  January 2016
Price:  From

Specialty Drug Distribution Market Analysis (2015 - 2020): By Drug Type (Oncology, Multiple Sclerosis, Rheumatoid Arthritis, Hemophilia); By Distribution (Retail, Home Health, Clinics, Pharmacies)

Specialty Drugs are used to treat chronic diseases such as Cancer, Multiple Sclerosis and Rheumatoid Arthritis. Specialty Drugs are injectable, oral or inhaled in nature which are prescribed by the...

Published:  June 2015
Price:  From

Global Cervical Cancer Market 2015-2019

About cervical cancer Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world's fourth most common cause of death in women. The disease can be classified...

Published:  September 2015
Price:  From

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

About non-small cell lung cancer therapeutics Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading...

Published:  October 2015
Price:  From

Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025

Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues to...

Published:  July 2015
Price:  From

Global Colorectal Cancer Drugs Market 2015-2019

About Colorectal Cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature...

Published:  June 2015
Price:  From

Global Kidney Cancer Drugs Market 2015-2019

About Kidney Cancer Kidney cancer also known as renal cancer affects the kidney cells. RCC is the most common form of kidney cancer in adults and Wilms' tumor in children. The exact cause of the disease...

Published:  July 2015
Price:  From

T-Cell Immunotherapy Market, 2015-2030

This report provides an extensive study of the field of T-cell immunotherapy. With no marketed products, this emerging field is still in its infancy; the report provides a comprehensive view of the...

Published:  October 2015
Price:  From

Global Cancer Pain Therapeutics Market 2015-2019

About Cancer Pain Therapeutics Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individual's...

Published:  January 2016
Price:  From
Loading Indicator

Our Clients